April 16, 2018 / 11:13 AM / in 4 months

BRIEF-Navidea Signs Deal To Sublicense Nav4694 Worldwide Development Rights

April 16 (Reuters) - Navidea Biopharmaceuticals Inc :

* NAVIDEA SIGNS DEAL TO SUBLICENSE NAV4694 WORLDWIDE DEVELOPMENT RIGHTS

* NAVIDEA BIOPHARMACEUTICALS INC - ANNOUNCED IT HAS SIGNED A DEAL TO PROVIDE MEILLEUR TECHNOLOGIES WORLDWIDE RIGHTS TO CONDUCT RESEARCH USING NAV4694

* NAVIDEA BIOPHARMACEUTICALS - AS A RESULT OF AGREEMENT, LITIGATION INITIATED BY BEIJING SINOTAU MEDICAL RESEARCH CO., LTD WILL BE DISMISSED Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below